NCT04446052已完成3 期
Phase III Study Priming With rhu_GM-CSF and of Three Induction Regimens in Adult Patients (55 and Over) With Acute Non-Lymphocytic Leukemia
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 362
- 主要终点
- complete remission rates
研究概览
简要总结
Phase III Study of Priming with Granulocyte-Macrophage Colony Stimulating Factor (rhu-GM-CSF) and ofThree Induction Regimens in Adult Patients (Over 55) with Acute Non-Lymphocytic Leukemia
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 56 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients with acute non-lymphocytic leukemia are eligible for the study.
排除标准
- 未提供
研究组 & 干预措施
GM-CSF priming
Active Comparator
干预措施: GM-CSF priming (Drug)
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
complete remission rates
时间窗: 3 years
次要结局
未报告次要终点
研究者
相似试验
终止
3 期
STem cElls Mobilization in Acute Myocardial Infarction Outcome TrialAnterior Acute Myocardial InfarctionLeft Ventricular Systolic DysfunctionNCT01969890Heart Care Foundation532
Unknown
2 期
RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon CancerColon CancerNCT02466906The Affiliated Hospital of the Chinese Academy of Military Medical Sciences60
已完成
2 期
GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon CancerColorectal CancerNCT00262808University of Rochester50
已完成
2 期
Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure SyndromesShwachman SyndromeFanconi's AnemiaDyskeratosis CongenitaThrombocytopeniaNCT00004787National Center for Research Resources (NCRR)20
已完成
早期 1 期
Study of the Effect of GM-CSF on Macrophages in EpendymomaEpendymoma, Recurrent ChildhoodEpendymomaNCT04408092University of Colorado, Denver6